Celltrion
068270.KS
#754
Rank
โ‚ฌ24.91 B
Marketcap
120,31ย โ‚ฌ
Share price
0.72%
Change (1 day)
6.26%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total debt

Total debt on the balance sheet as of March 2024 : โ‚ฌ1.49 Billion

According to Celltrion 's latest financial reports the company's total debt is โ‚ฌ1.49 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Celltrion - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚ฌ0.58 B6.05%
2021-12-31โ‚ฌ0.55 B-4.68%
2020-12-31โ‚ฌ0.57 B51.54%
2019-12-31โ‚ฌ0.38 B-5.46%
2018-12-31โ‚ฌ0.40 B-19.27%
2017-12-31โ‚ฌ0.50 B-6.43%
2016-12-31โ‚ฌ0.53 B-13.53%
2015-12-31โ‚ฌ0.61 B-2.43%
2014-12-31โ‚ฌ0.63 B23.3%
2013-12-31โ‚ฌ0.51 B18%
2012-12-31โ‚ฌ0.43 B57.56%
2011-12-31โ‚ฌ0.27 B50.94%
2010-12-31โ‚ฌ0.18 B21.66%
2009-12-31โ‚ฌ0.15 B12.89%
2008-12-31โ‚ฌ0.13 B562.58%
2007-12-31โ‚ฌ20.15 M